Literature DB >> 21386625

Three-drug combination regimen in pancreatic cancer treatment: are we there yet?

Soonmo Peter Kang, Muhammad Wasif Saif.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21386625

Source DB:  PubMed          Journal:  JOP        ISSN: 1590-8577


× No keyword cloud information.
  1 in total

1.  A retrospective study of neoadjuvant FOLFIRINOX in unresectable or borderline-resectable locally advanced pancreatic adenocarcinoma.

Authors:  Peter J Hosein; Jessica Macintyre; Carolina Kawamura; Jennifer Cudris Maldonado; Vinicius Ernani; Arturo Loaiza-Bonilla; Govindarajan Narayanan; Afonso Ribeiro; Lorraine Portelance; Jaime R Merchan; Joe U Levi; Caio M Rocha-Lima
Journal:  BMC Cancer       Date:  2012-05-29       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.